These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36495861)

  • 21. Clinical target sequencing for precision medicine of breast cancer.
    Tsuchida J; Rothman J; McDonald KA; Nagahashi M; Takabe K; Wakai T
    Int J Clin Oncol; 2019 Feb; 24(2):131-140. PubMed ID: 30604156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precision oncology for breast cancer through clinical trials.
    Blucher AS; Mills GB; Tsang YH
    Clin Exp Metastasis; 2022 Feb; 39(1):71-78. PubMed ID: 33950412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actionable data for precision oncology: Framing trustworthy evidence for exploratory research and clinical diagnostics.
    Tempini N; Leonelli S
    Soc Sci Med; 2021 Mar; 272():113760. PubMed ID: 33601250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.
    Chae YK; Pan AP; Davis AA; Patel SP; Carneiro BA; Kurzrock R; Giles FJ
    Mol Cancer Ther; 2017 Dec; 16(12):2645-2655. PubMed ID: 29203694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
    Yoon H; Lee S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actionable gene-based classification toward precision medicine in gastric cancer.
    Ichikawa H; Nagahashi M; Shimada Y; Hanyu T; Ishikawa T; Kameyama H; Kobayashi T; Sakata J; Yabusaki H; Nakagawa S; Sato N; Hirata Y; Kitagawa Y; Tanahashi T; Yoshida K; Nakanishi R; Oki E; Vuzman D; Lyle S; Takabe K; Ling Y; Okuda S; Akazawa K; Wakai T
    Genome Med; 2017 Oct; 9(1):93. PubMed ID: 29089060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
    Condorelli R; Mosele F; Verret B; Bachelot T; Bedard PL; Cortes J; Hyman DM; Juric D; Krop I; Bieche I; Saura C; Sotiriou C; Cardoso F; Loibl S; Andre F; Turner NC
    Ann Oncol; 2019 Mar; 30(3):365-373. PubMed ID: 30715161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing a comprehensive translational oncology platform: from molecular testing to actionability.
    Mitri ZI; Parmar S; Johnson B; Kolodzie A; Keck JM; Morris M; Guimaraes AR; Beckett BR; Borate U; Lopez CD; Kemmer KA; Alumkal JJ; Beer TM; Corless CL; Mills GB; Gray JW; Bergan RC
    J Transl Med; 2018 Dec; 16(1):358. PubMed ID: 30551737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
    Zivanovic Bujak A; Weng CF; Silva MJ; Yeung M; Lo L; Ftouni S; Litchfield C; Ko YA; Kuykhoven K; Van Geelen C; Chandrashekar S; Dawson MA; Loi S; Wong SQ; Dawson SJ
    PLoS Med; 2020 Oct; 17(10):e1003363. PubMed ID: 33001984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
    Sultova E; Westphalen CB; Jung A; Kumbrink J; Kirchner T; Mayr D; Rudelius M; Ormanns S; Heinemann V; Metzeler KH; Greif PA; Burges A; Trillsch F; Mahner S; Harbeck N; Wuerstlein R
    Arch Gynecol Obstet; 2021 May; 303(5):1331-1345. PubMed ID: 33277683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic Alteration in Metastatic Breast Cancer and Its Treatment.
    Li A; Schleicher SM; Andre F; Mitri ZI
    Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-14. PubMed ID: 32213086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploiting rare driver mutations for precision cancer medicine.
    Scholl C; Fröhling S
    Curr Opin Genet Dev; 2019 Feb; 54():1-6. PubMed ID: 30844512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standard and Genomic Tools for Decision Support in Breast Cancer Treatment.
    Henry NL; Bedard PL; DeMichele A
    Am Soc Clin Oncol Educ Book; 2017; 37():106-115. PubMed ID: 28561710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precision medicine in breast cancer.
    Naito Y; Urasaki T
    Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
    Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
    Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic Analyses and Precision Oncology in Gastroesophageal Cancer: Forwards or Backwards?
    Sundar R; Tan P
    Cancer Discov; 2018 Jan; 8(1):14-16. PubMed ID: 29311223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
    Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
    Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
    [No Abstract]   [Full Text] [Related]  

  • 38. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.
    Dumbrava EI; Meric-Bernstam F
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29212833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genomics and clinical research for breast cancer].
    Bertucci F; Birnbaum D
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.
    Hayashi H; Tanishima S; Fujii K; Mori R; Okada C; Yanagita E; Shibata Y; Matsuoka R; Amano T; Yamada T; Yabe I; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
    Cancer Sci; 2020 Oct; 111(10):3926-3937. PubMed ID: 32772458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.